another new "glitazone" for type 2 diabetes, Actos (pioglitazone)

You'll soon see another new "glitazone" for type 2 diabetes, Actos (pioglitazone).

This is the third one...after Rezulin (troglitazone) and Avandia (rosiglitazone).

These drugs lower blood glucose by improving insulin sensitivity.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote